Autopsy report · NCT00585000
A Study To Assess The Safety Of Administering CP-675,206 As A One Hour Infusion In Patients With Surgically Incurable Advanced Melanoma
Cause of deathNo reason given
“See termination reason in detailed description.”
Life of this trial
- Ran for about 2 years 1 month before it stopped.
- 49 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- AstraZeneca
- Sponsor type
- Industry
- Conditions
- Melanoma
- Interventions
- CP-675,206
- Participants
- 49
- Sites
- 8
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.